Universal Health Services Inc. (UHS) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Universal Health Services Inc. (UHS) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How UHS Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $17.36B | 44% | 11.5% | $1.49B | $849.2M | 14.1% |
| FY 2024 | $15.83B | 44% | 10.6% | $1.14B | $1.12B | 12.1% |
| FY 2023 | $14.28B | 44% | 8.2% | $717.8M | $625.1M | 9% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring UHS)
- ✓Live walkthrough of UHS's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
UHS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on UHS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for UHS. Explore sector supply chains on /butterfly.
UHS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Universal Health Services Inc. (UHS)?
In FY 2025 (10-K), UHS converted $17.4B of revenue into a 44% gross margin, 11.5% operating margin, and $849.2M in free cash flow (4.9% FCF margin).